We are live on
!
Find out more
RCI
Ridgeback Capital Investments Portfolio holdings
AUM
$560K
This Fund
S&P 500
This Quarter
Est. Return
+29.21%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$184M
AUM Growth
–
Cap. Flow
+$178M
Cap. Flow
% of AUM
97.07%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
3
New
3
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
BCYC
Bicycle Therapeutics
BCYC
|
+$119M |
| 2 |
AFMD
Affimed
AFMD
|
+$47.7M |
| 3 |
FSTX
F-star Therapeutics, Inc. Common Stock
FSTX
|
+$11.1M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 100% |
Similar funds
LPARFS
SC
ZIMP
XS
B
AMG
SFG
CIM
Ridgeback Capital Investments's Q4 2021 Portfolio in Review
Q4 2021 is the first quarter with a 13F filing on record for Ridgeback Capital Investments, which disclosed 3 positions worth $184M. Its ten largest holdings account for 100% of the portfolio.
Its largest position is Bicycle Therapeutics: 2,164,801 shares worth $132M.
By sector, the portfolio is most concentrated in Healthcare at 100% of assets.
- Ridgeback Capital Investments's largest Q4 2021 buy was Bicycle Therapeutics: 2,164,801 shares worth $132M.
- Ridgeback Capital Investments's ten largest holdings make up 100% of its $184M portfolio in Q4 2021.
- Ridgeback Capital Investments disclosed 3 positions in Q4 2021, its first 13F filing on record.
Based on Ridgeback Capital Investments's 13F filing for Q4 2021, filed 14 Feb 2022.